title: Metabolic Glyco-Engineering in Eukaryotic Cells and Selected Applications.
abstract: By metabolic glyco-engineering cellular glycoconjugates are modified through the incorporation of synthetic monosaccharides which are usually analogues of naturally present sugars. In order to get incorporated, the monosaccharides need to enter the cytoplasm and to be substrates for the enzymes necessary for their transformation into activated sugars, most often nucleotide sugars. These have to be substrates for glycosyltransferases which finally catalyze their incorporation into glycans. Such pathways are difficult to reconstitute in vitro and therefore new monosaccharide analogues have to be tested in tissue culture for their suitability in metabolic glyco-engineering. For this, glycosylation mutants are the most appropriate since they are unable to synthesize specific glycans but through the introduction of the monosaccharide analogues they may express some glycans at the cell surface with the unnatural sugar incorporated. The presence of those glycans can be easily and quantitatively detected by lectin binding or by chemical methods identifying specific sugars. Monosaccharide analogues can also block the pathways leading to sugar incorporation, thus inhibiting the synthesis of glycan structures which is also easily detectable at the cell surface by lectin labeling. The most useful and most frequently employed application of metabolic glyco-engineering is the introduction of reactive groups which can undergo bio-orthogonal click reactions for the efficient labeling of glycans at the surface of live cells.
authors.affiliation: Synthetic Protein Chemistry and Glyco-engineering Group, Centre de Biophysique Moléculaire (CNRS UPR 4301), Orléans, France.
authors.forename: Friedrich
authors.initials: F
authors.lastname: Piller
authors.forename: Aline
authors.initials: A
authors.lastname: Mongis
authors.forename: Véronique
authors.initials: V
authors.lastname: Piller
mesh_terms: D000818:Animals; D016466:CHO Cells; D002460:Cell Line; D003412:Cricetulus; D005057:Eukaryotic Cells / Q000378:metabolism*; D006001:Glycoconjugates / Q000378:metabolism; D006031:Glycosylation; D016695:Glycosyltransferases / Q000378:metabolism*; D006801:Humans; D037102:Lectins / Q000378:metabolism; D060847:Metabolic Engineering / Q000379:methods; D009005:Monosaccharides / Q000378:metabolism; D011134:Polysaccharides / Q000378:metabolism*
chemical_list: D006001:Glycoconjugates; D037102:Lectins; D009005:Monosaccharides; D011134:Polysaccharides; D016695:Glycosyltransferases